Merck withdraws cholesterol drug Tredaptive globally
Jan 11 (Reuters) - Merck & Co Inc said it would withdraw its cholesterol drug Tredaptive from markets worldwide after European regulators recommended that marketing of the drug be suspended.
The drug was under review in Europe after the failure of a major study raised safety concerns.
Merck recommended that physicians stop prescribing the drug and review treatment plans for patients taking it.
- Mexican train derails, stranding 1,300 migrants headed toward U.S.
- Israeli strikes kill more Palestinians; rocket causes huge blaze in Israel |
- Man suspected of shooting six dead in Texas to appear in court
- Four servicemen, five miners killed in eastern Ukraine |
- Obama tells Israel U.S. ready to help end hostilities